{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:34:43Z","timestamp":1786422883787,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinre.2024.102496","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:10:31Z","timestamp":1731489031000},"page":"102496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-8016","authenticated-orcid":false,"given":"Manon","family":"Allaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Meyblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Goumard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Rudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Scatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinre.2024.102496_bib0001","first-page":"908\u201143","article-title":"European Association For The Study Of The Liver, European organisation for research and treatment of cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2024.102496_bib0002","doi-asserted-by":"crossref","first-page":"681\u201193","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102496_bib0003","first-page":"41\u201153","article-title":"Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. United","volume":"10","author":"M\u00fcller","year":"2022","journal-title":"European Gastroenterol J"},{"issue":"5","key":"10.1016\/j.clinre.2024.102496_bib0004","doi-asserted-by":"crossref","first-page":"2184\u201193","DOI":"10.1007\/s00330-017-5145-9","article-title":"Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"28","author":"Choi","year":"2018","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.clinre.2024.102496_bib0005","doi-asserted-by":"crossref","first-page":"1734\u201143","DOI":"10.1111\/liv.14977","article-title":"Portal hypertension and hepatocellular carcinoma: des liaisons dangereuses\u2026","volume":"41","author":"Allaire","year":"2021","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.clinre.2024.102496_bib0006","first-page":"985\u201197","article-title":"Portal-hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy. United","volume":"11","author":"Giudicelli","year":"2023","journal-title":"European Gastroenterol J"},{"issue":"6","key":"10.1016\/j.clinre.2024.102496_bib0007","doi-asserted-by":"crossref","first-page":"2079\u201188","DOI":"10.1002\/hep.26629","article-title":"Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study","volume":"58","author":"Ripoll","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102496_bib0008","first-page":"S1590","article-title":"Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab","volume":"24","author":"Sultanik","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2024.102496_bib0009","first-page":"S0168","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"22","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"issue":"10181","key":"10.1016\/j.clinre.2024.102496_bib0010","first-page":"1597\u2011608","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet North Am Ed"},{"issue":"4","key":"10.1016\/j.clinre.2024.102496_bib0011","first-page":"959\u201174","article-title":"Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"de","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102496_bib0012","doi-asserted-by":"crossref","first-page":"213\u201123","DOI":"10.1097\/HEP.0000000000000291","article-title":"Portal hypertension and variceal bleeding in patients with liver cancer: evidence gaps for prevention and management","volume":"79","author":"Allaire","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102496_bib0013","doi-asserted-by":"crossref","first-page":"563\u201176","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102496_bib0014","doi-asserted-by":"crossref","first-page":"188\u201198","DOI":"10.1007\/s12072-011-9338-z","article-title":"Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy","volume":"7","author":"Hsu","year":"2013","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.clinre.2024.102496_bib0015","doi-asserted-by":"crossref","first-page":"3354\u201162","DOI":"10.1007\/s10620-016-4255-6","article-title":"Primary prophylaxis for variceal bleeding and the improved survival of patients with newly diagnosed hepatocellular carcinoma","volume":"61","author":"Kim","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.clinre.2024.102496_bib0016","doi-asserted-by":"crossref","first-page":"500\u20118","DOI":"10.5009\/gnl19155","article-title":"Treatment outcomes and prognostic factors of acute variceal bleeding in patients with hepatocellular carcinoma","volume":"14","author":"Lee","year":"2020","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.clinre.2024.102496_bib0017","first-page":"682\u201190","article-title":"Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial","volume":"73","author":"Yang","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2024.102496_bib0018","doi-asserted-by":"crossref","first-page":"86\u201194","DOI":"10.1016\/j.dld.2018.07.014","article-title":"Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis","volume":"51","author":"Allaire","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2024.102496_bib0019","doi-asserted-by":"crossref","first-page":"526\u201136","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102496_bib0020","doi-asserted-by":"crossref","first-page":"743\u201152","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2024.102496_bib0021","doi-asserted-by":"crossref","first-page":"1634\u201141","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.clinre.2024.102496_bib0022","doi-asserted-by":"crossref","first-page":"1162\u20119","DOI":"10.1111\/apt.14576","article-title":"Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study","volume":"47","author":"Schwarzer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.clinre.2024.102496_bib0023","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/liv.15458","article-title":"A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC","volume":"42","author":"Larrey","year":"2022","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clinre.2024.102496_bib0024","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.17599","article-title":"Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma","volume":"58","author":"Allaire","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.clinre.2024.102496_bib0025","doi-asserted-by":"crossref","first-page":"573\u20117","DOI":"10.1097\/MEG.0b013e32834701f5","article-title":"Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension","volume":"23","author":"Elia","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2024.102496_bib0026","doi-asserted-by":"crossref","first-page":"850\u20118","DOI":"10.1177\/2050640619840199","article-title":"Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma","volume":"7","author":"Scheiner","year":"2019","journal-title":"United European Gastroenterol J"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:18:54Z","timestamp":1737332334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2210740124002171"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102496","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102496"}}